Page last updated: 2024-08-26

prolinedithiocarbamate and Adenocarcinoma of Lung

prolinedithiocarbamate has been researched along with Adenocarcinoma of Lung in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
DU, JX; Gong, WX; Huang, SC; Liang, CW; Pan, Y; Peng, DX; Quan, W; Wang, X; Xie, Y; Zhang, N; Zheng, LP	1

Other Studies

1 other study(ies) available for prolinedithiocarbamate and Adenocarcinoma of Lung

Article	Year
[Activation of nuclear factor-κB subunit p50/p65 enhances gefitinib resistance of lung adenocarcinoma H1650 cell line]. Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2018, May-20, Volume: 38, Issue:5 Topics: Adenocarcinoma of Lung; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Gefitinib; Humans; NF-kappa B p50 Subunit; Proline; Thiocarbamates; Transcription Factor RelA	2018

Article

Year

[Activation of nuclear factor-κB subunit p50/p65 enhances gefitinib resistance of lung adenocarcinoma H1650 cell line].

Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2018, May-20, Volume: 38, Issue:5

Topics: Adenocarcinoma of Lung; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Gefitinib; Humans; NF-kappa B p50 Subunit; Proline; Thiocarbamates; Transcription Factor RelA

2018